Randomized, single‐blind, trial of sertraline and buspirone for treatment of elderly patients with generalized anxiety disorder
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Aim: Generalized anxiety disorder (GAD) in elderly people is common, but few systematic studies regarding the best treatments have been performed. The aim of the present study was to evaluate the efficacy and safety of sertraline and buspirone in the treatment of elderly patients with GAD. Methods: Based on selection criteria, 46 patients were recruited who met DSM‐IV criteria for GAD. Patients were randomly assigned to sertraline (50–100 mg/day) or buspirone (10–15 mg/day) for 8 weeks in a single‐blind trial. The primary outcome measure used in the present study was the Hamilton Rating Scale for Anxiety (HRSA). Results: Both sertraline and buspirone had significant anxiolytic efficacy. A steady decrease in the total HRSA scores for both groups was observed throughout the study period. After 2 and 4 weeks, buspirone was found to be significantly superior to sertraline (P < 0.001), but at the end of study period this difference did not reach statistical significance (P = 0.16). The mean HRSA score after 8 weeks significantly decreased in subjects treated with sertraline (P < 0.001), and buspirone (P < 0.001). No clinically adverse events or changes in laboratory test results were observed during the study period. Conclusion: Both sertraline and buspirone appear to be efficacious and well tolerated in the treatment of GAD in elderly patients. Further studies with larger sample size, evaluating the effect of medical illness, cognitive impairment, depression, and combined therapy with support and psychotherapy are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling Acute Episodes of Depression
LAPIERRE, Y. D. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199112002-00005 · Cited by 27
Ragneskog, H., Eriksson, S., Karlsson, I., & Gottfries, C.-G. (1996) · International Psychogeriatrics · doi:10.1017/s1041610296002967 · Cited by 22
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“Pregabalin [576,577,592,593,597,613] 1 Buspirone [108,561,572,589,598,618,619] 1”
BackgroundInfluentialAndrews, G., Bell, C., Boyce, P., Gale, C., Lampe, L., Marwat, O., Rapee, R., & Wilkins, G. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418799453 · Cited by 243
Interventions for generalized anxiety disorder in older adults: Systematic review and meta-analysis
Gonçalves, D. C., & Byrne, G. J. (2012) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2011.08.010 · Cited by 227
“Placebo was used as the control condition in all pharmacological rials except one, which compared the efficacy of buspirone with ertraline (Mokhber et al., 2010).”
InfluentialNew Research on Anxiety Disorders in the Elderly and an Update on Evidence-Based Treatments
Andreescu, C., & Varon, D. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0595-8 · Cited by 85
Metadata
- Authors
- Mokhber, N., Azarpazhooh, M. R., Khajehdaluee, M., Velayati, A., & Hopwood, M.
- Venue
- Psychiatry and Clinical Neurosciences
- Publisher
- Wiley
- Published
- 2010-03-24
- Volume
- 64
- Issue
- 2
- Pages
- 128-133
- ISSN
- 1323-1316 (ISSN-L)
- 1440-1819
- OpenAlex
- W2083473891
- Cited by
- 55
- References
- 2
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomized, single‐blind, trial of sertraline and buspirone for treatment of elderly patients with generalized anxiety disorder. https://app.cochat.ai/papers/10.1111/j.1440-1819.2009.02055.x
- The paper
- Mokhber, N., Azarpazhooh, M. R., Khajehdaluee, M., Velayati, A., & Hopwood, M. (2010). Randomized, single‐blind, trial of sertraline and buspirone for treatment of elderly patients with generalized anxiety disorder. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.2009.02055.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.